When your electrical system is working normally, the two upper chambers of the heart (atria) contract and pump blood into the two lower chambers (ventricles) in a well-coordinated way. This results in ...

Compared with regular checks in primary care, continuous ECG monitoring revealed more asymptomatic older people with hypertension as having atrial fibrillation (Afib), the SCREEN-AF trial showed. The ...

Researchers in Canada and Germany conducted the SCREEN-AF trial, a multicenter, open-label, randomized clinical trial of noninvasive, home-based AF screening interventions in community-dwelling older ...

(RTTNews) - Tempus AI, Inc (TEM), Wednesday announced that the company has received 510(k) clearance from the U.S. Food and Drug Administration for its Tempus ECF-AF, which utilizes AI to detect ...

Please provide your email address to receive an email when new articles are posted on . Two studies found that mass screening for atrial fibrillation in older adults does not reduce stroke. In one ...

Fitbit has completed clinical trials of its own ECG feature and is looking to get FDA approval – as it launches a large scale study into Afib and irregular heart rate detection. The mass Fitbit Heart ...

“I think you’ll be able to look back at some point in the future, and Apple’s greatest contribution will have been to people’s health. I think it’s that big.” This strong conviction comes from none ...

MADRID -- Remote screening yielded new cases of atrial fibrillation (Afib or AF) in the general population that otherwise would have gone undetected and untreated, according to the AMALFI trial in the ...

Extended cardiac monitoring in patients and the use of implantable cardiovascular electronic devices can increase detection of atrial fibrillation (AF), but the devices have limitations including ...

CHICAGO--(BUSINESS WIRE)--Tempus AI, Inc. (NASDAQ: TEM), a leader in artificial intelligence and precision medicine, today announced it has received 510(k) clearance from the U.S. Food and Drug ...